In January 2016, Joe Farago joined Innovative Medicines Canada. He is currently the executive director, private payers and investment, responsible for the private payer market, pCPA and the national innovation strategy.

Farago is leading the pharmaceutical sectors efforts in taking a more proactive, research-based approach to addressing today’s policy issues. Part of his efforts include being an advocate for Canada’s dual market of private and public coverage ensuring employees and their families have timely access to innovative medicine to help keep them healthy and productive.

Farago has acquired a vast knowledge of the Canadian pharmaceutical and specialty biopharmaceutical markets. He has a wide range of experience in market access, government affairs, sales, marketing and operations. He has had the opportunity to be part of establishing two organizations in the Canadian market from the ground up and brings a strong understanding of market access success and organizational development. Farago started his pharmaceutical career with Servier Canada in 1989 until he entered the plasma protein specialty market with CSL Limited in 2007, where he was instrumental in establishing and building the Canadian organization to a market leader.

He attended Carleton University, graduating with a BSc and lives in Manotick, Ont. with his wife and their three children.